NeoGenomics Inc.

NASDAQ: NEO · Real-Time Price · USD
6.21
0.01 (0.16%)
At close: Aug 15, 2025, 3:59 PM
6.29
1.21%
After-hours: Aug 15, 2025, 06:17 PM EDT

NeoGenomics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
367.01M 342.49M 263.18M 316.83M
Short-Term Investments
19.83M 72.72M 174.81M 198.56M
Long-Term Investments
n/a n/a 31K 236K
Other Long-Term Assets
5.89M 4.74M -29.67M -48.54M
Receivables
150.54M 131.26M 119.71M 112.13M
Inventory
26.75M 24.16M 24.28M 23.39M
Other Current Assets
11.72M 8.2M 8.08M 18.24M
Total Current Assets
596.02M 596.81M 605.29M 681.51M
Property-Plant & Equipment
173.69M 183.78M 198.61M 211.66M
Goodwill & Intangibles
862.45M 895.89M 931.03M 969.44M
Total Long-Term Assets
1.04B 1.08B 1.13B 1.19B
Total Assets
1.64B 1.68B 1.74B 1.87B
Account Payables
21.61M 20.33M 20.51M 17.92M
Deferred Revenue
409K 2.13M 7.56M 5.19M
Short-Term Debt
200.78M n/a n/a n/a
Other Current Liabilities
75.07M 53.16M 15.07M 17.8M
Total Current Liabilities
301.24M 96.3M 89.93M 87.23M
Long-Term Debt
340.33M 538.2M 535.32M 532.48M
Other Long-Term Liabilities
11.77M 13.03M 13.05M 13.03M
Total Long-Term Liabilities
434.46M 643.39M 652.08M 674.27M
Total Liabilities
735.7M 739.69M 742.01M 761.5M
Total Debt
605.33M 611.68M 610.93M 612.79M
Common Stock
128K 127K 127K 124K
Retained Earnings
-325.78M -247.06M -159.09M -14.84M
Comprehensive Income
-206K -1.67M -3.9M -638K
Shareholders Equity
902.34M 941.54M 998.02M 1.11B
Total Investments
19.83M 72.72M 174.81M 198.56M